Vhl Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
VHL (Von Hippel-Lindau tumor suppressor) encodes the VHL protein, a key regulator of the hypoxia-inducible factor (HIF) pathway. While classically associated with VHL disease—a hereditary cancer syndrome—VHL plays critical roles in neuronal survival under hypoxic conditions and is increasingly recognized in neurodegenerative disease pathogenesis[1].
The VHL protein is the substrate recognition component of an E3 ubiquitin ligase complex that targets HIF-α subunits for proteasomal degradation under normal oxygen conditions:
Beyond HIF regulation, VHL has other cellular roles:
VHL/HIF pathway dysregulation is implicated in Alzheimer's disease:
In Parkinson's disease:
VHL is critically important in acute brain injury:
VHL involvement in Huntington's disease:
VHL is expressed in most tissues:
The VHL/HIF pathway is therapeutically relevant:
The study of Vhl Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Kaelin WG. (2008). The von hippel-lindau tumour suppressor protein: O2 sensing and cancer. Nat Rev Cancer. 8(11):865-873. PMID:18923434 ↩︎
Schofield CJ, Ratcliffe PJ. (2004). Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol. 5(5):343-354. PMID:15122348 ↩︎
Gossage L, Eisen T. (2010). VHL, the story of a tumour suppressor gene. Nat Rev Cancer. 10(1):51-62. PMID:20029422 ↩︎
Li L, et al. (2009). Hypoxia and Alzheimer's disease. J Alzheimers Dis. 17(3):535-543. PMID:19502724 ↩︎
Lee DW, et al. (2015). Hypoxia in dopaminergic neurodegeneration. J Neural Transm Suppl. 2015(79):39-47. PMID:25548186 ↩︎
Siddiq A, et al. (2009). Prolyl hydroxylase inhibition results in expression of neuroprotective hypoxia-inducible factor. Brain Res. 1286:116-124. PMID:19505450 ↩︎
Terni B, et al. (2010). HIF-1alpha is involved in the response to huntingtin toxicity. Neurobiol Dis. 40(3):590-596. PMID:20696238 ↩︎
Bernhardt WM, et al. (2006). Targeting hypoxia in cancer therapy. Nat Rev Cancer. 6(7):509-519. PMID:16793929 ↩︎